Dear ISHers, Please find below a few announcements (1) PSA - ISHPSSB cognate session (2) PSA - The International Philosophy of Medicine Roundtable cognate session (3) CfP - Conference "Evidence-Based Medicine Reconsidered" Have a good day, Lucie *(1) PSA - ISHPSSB cognate session* Dear ISH Community, If you are attending the PSA conference in New Orleans this week, we warmly invite you to join the ISHPSSB cognate session, entitled "Into the Red: Philosophical Issues in Risk Categorisation, Classification, and Concept Formation at the Edge of Extinction": *Date & Time*: Thursday at 10:15 AM *Location: *Studio 4 *Abstract*: Together with the climate crisis, the biodiversity crisis is at the center of global risk assessment and scenario-building exercises at the science-policy interface. But unlike the climate crisis, the biodiversity crisis has received scant attention from philosophers of science interested in the complex epistemic and ethical roles of non- and intergovernmental actors that govern these large-scale scientific endeavors. This symposium seeks to address this gap by critically examining the assessment tools, conceptual framings, and classification strategies of the International Union for Conservation of Nature (IUCN). As the producer of the authoritative Red List of Threatened Species (RLS) and Red List of Threatened Ecosystems (RLE), the IUCN plays a pivotal role in setting the conceptual and ethical stage for science-policy interventions that aim to mitigate the biodiversity crisis. This symposium will address the tensions between conceptualizations of ‘care’ and ‘objectivity’ that inform the governance structure of the RLS (Beckett Sterner), analyze the problematic effects of performativity that result from the uptake of the RLS risks categorization in conservation practice (Joeri Witteveen), examine the trade-offs between global and local classification schemes for conservation units (Lara Sabatier), and develop a new account of the notion of ‘ecosystem collapse’ that is at the heart of the RLE (Max Dresow and Michael Bennett McNulty). We look forward to seeing many of you there! Best regards, Joeri Witteveen *(2) PSA - The International Philosophy of Medicine Roundtable cognate session* The International Philosophy of Medicine Roundtable cognate session will take place on Thursday 14 November from 8:30-10:00 am in Studio 4. The topic is "What can HPS and STS contribute to debates about replacing experimental animals with NAMs?" The session will include: - The uncertain ontological status of organoids by Charles H. Pence (presenter) and Maxence Gaillard - Using a repertoires framework to understand impediments and drivers of alternatives to animal research models by Rachel A. Ankeny - Facing NAMs: Exploring the potentials of human and other-than-human encounters in the building of non-animal models for neuroscience research by Sophia Efstathiou (presenter), Emma Roe, and Ioanna Sandvig - Commentary by Sara Green followed by audience and panel discussion For more details, please see the PSA program at https://site.pheedloop.com/event/psa24/program/schedule. We look forward to seeing you there! *(3) CfP - Conference "Evidence-Based Medicine Reconsidered"* *CALL FOR PAPERS - Deadline is November 17* *Conference Dates: April 5-6th, 2025* University of Pittsburgh, Pittsburgh, PA Senior Visiting Fellow Conference by Carl Hoefer The evidence-based medicine (EBM) movement began in the 1980s, reached its peak perhaps in the 1990s, and has since then enjoyed the status of orthodoxy, despite many criticisms being raised among medical practitioners and researchers. Philosophers of medicine have frequently criticized EBM’s hierarchies and rigid precepts, especially the “gold standard” status of randomized controlled trials (RCTs). A pluralistic approach to evidence in medicine has been increasingly popular in recent years, in which mechanistic evidence and reasoning, observational studies of many kinds and RCTs are assessed for value on a case-by-case basis. But does this trend away from the EBM hierarchy go too far and risk the reintroduction of the same biased, motivated evidence-gathering practices that originally motivated the EBM movement? What light can recent experiences in medicine and public health (e.g., during the covid-19 pandemic) shed on these issues? Visit the website for the most up-to- date information and registration: https://www.centerphilsci.pitt.edu/event/evidence-based-medicine-reconsidered/ *Call for Abstracts* We invite papers which address topics related to evidence in medicine, broadly speaking. These include, but are not limited to: - Defenses (or criticisms) of the supposed superiority of RCTs over observational studies, mechanistic studies, modeling, and individual clinical judgment; - Discussions of lessons that philosophy of medicine or EBM can learn from recent experiences; - Papers offering theoretical discussions of procedures for integrating and evaluating evidence from different sources; - The merits and limitations of emerging kinds of medical evidence, such as adaptive trials, so-called real-world evidence, precision or personalized medicine research, and big data research - Evidence in diverse contexts, such as clinical practice, alternative healthcare, drug or device regulation, public health, and health policy. *Abstracts should be between 500-800 words long and should be sent by November 17th to:* [log in to unmask]